Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology (Nature Cancer, (2022), 3, 2, (251-261), 10.1038/s43018-022-00332-x)

Cancer Core Europe consortium

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

In this article, the Code availability section has been updated to clarify conditions for access and to revise the repository link. The new statement now reads “Aggregated results shown in this article were created using Python (>3.5) NumPy, Pandas and Matplotlib open-source libraries. The code for the MTBP components reproducing the variant annotation framework discussed in the manuscript has been deposited to Zenodo with access restricted for research use only (see https://doi.org/10.5281/zenodo.6376428 for terms of use details). Access to other components available in MTBP production systems can be provided upon agreement with the copyright holders.” The change has been made in the HTML and PDF versions of the article.

Original languageEnglish (US)
Pages (from-to)649
Number of pages1
JournalNature Cancer
Volume3
Issue number5
DOIs
StatePublished - May 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

MD Anderson CCSG core facilities

  • Clinical and Translational Research Center

Fingerprint

Dive into the research topics of 'Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology (Nature Cancer, (2022), 3, 2, (251-261), 10.1038/s43018-022-00332-x)'. Together they form a unique fingerprint.

Cite this